Association of serum magnesium levels with microvascular complications in type 2 diabetes mellitus, with significant correlation to diabetic retinopathy: a cross-sectional study
DOI:
https://doi.org/10.18203/2349-3933.ijam20262827Keywords:
Hypomagnesemia, Nephropathy, Neuropathy, Retinopathy, Type 2 diabetes mellitusAbstract
Background: Magnesium is essential for numerous biological processes, including glucose metabolism, insulin responsiveness and vascular integrity. A deficiency in magnesium is commonly reported in individuals with type 2 diabetes mellitus (T2DM) and is suspected to contribute to the development of microvascular complications such as nephropathy, retinopathy and neuropathy. This study aimed to evaluate the prevalence of hypomagnesemia in T2DM patients and explore its association with microvascular complications.
Methods: A cross-sectional, observational study was conducted at SRN Hospital, Prayagraj, involving 143 patients diagnosed with T2DM. Serum magnesium levels were estimated, with values below 1.7 mg/dl considered indicative of hypomagnesemia. Statistical analysis was used to examine relationships between magnesium levels and the occurrence of microvascular complications as nephropathy, retinopathy and neuropathy.
Results: Among the 143 participants (average age 57 years), hypomagnesemia was identified in 17.5% of cases. The overall mean serum magnesium concentration was 1.93±0.29 mg/dl. A significant inverse relationship was observed between serum magnesium levels and the presence of diabetic retinopathy (p=0.008); retinopathy was found in 60% of patients with hypomagnesemia compared to 29.66% of those with normal magnesium levels. Although nephropathy and neuropathy were more prevalent in the hypomagnesemia group (40% and 28%, respectively), these associations were not statistically significant.
Conclusions: The study found a significant link between magnesium deficiency and diabetic retinopathy, highlighting a potential role of hypomagnesemia in its pathogenesis. Regular monitoring of magnesium status in T2DM patients may help identify those at higher risk for microvascular complications.
References
Centers for Disease Control and Prevention. National Diabetes Statistics Report 2017: Estimates of Diabetes and Its Burden in the United States. Atlanta, GA: U.S. Department of Health and Human Services. 2017. Available at: https://www.cdc.gov/diabetes/ pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed on 21 January 2026.
American Diabetes Association. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2018. Diabetes Care. 2018;41(1):13–27.
Powers AC, Stafford JM, Rickels MR. Diabetes Mellitus: Complications. In: Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine. 20th ed. New York: McGraw-Hill. 2018: 2852.
Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366:1227–39.
American Diabetes Association. Microvascular complications and foot care: Standards of medical care in diabetes—2018. Diabetes Care. 2018;41(1):105–18.
International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: IDF Executive Office. 2015: 7.
Naqvi A, Shadani AK, Gupta S. Study of serum magnesium level in type 2 diabetes mellitus in relation to its microvascular complication. Int J Sci Healthc Res. 2022;7(2):108–17.
Hamarshih M, Hamshari S, Nazzal Z. Hypomagnesemia and poor glycemic control among type 2 diabetic patients: a cross-sectional study. Indian J Endocrinol Metab. 2022;26(6):575-80.
Kumar SR, Kumar KGS, Gayathri R. Hypomagnesemia in Patients with Type 2 Diabetes Mellitus. J Assoc Physicians India. 2024;72(7):25-8.
Prabhu G, Raadha AM, Balasubramaniyan S. A study of serum magnesium level in type 2 diabetes mellitus and its significance. Int J Med Res Rev. 2015;3(7):675–81.
Alswat K. Type 2 diabetes control and complications and their relation to serum magnesium level. Arch Med Sci. 2021;18(2):307–13.
Yossef HM, Ghanem NS, Al-Jarhi UM. Relation of serum magnesium level to microvascular complications and the components of metabolic syndrome in patients with type 2 diabetes mellitus. Egypt J Intern Med. 2017;29:100–4.
Roychowdhury D, Pal SK, Das B, Mandal P. Assessment of serum magnesium and correlation with glycemic control and complication in type 2 diabetes mellitus – A cross-sectional study in a tertiary care hospital in eastern zone of India. Natl J Physiol Pharm Pharmacol. 2023;13(3): 589-94.
Moradiya K, Muley A. A study of serum magnesium level in type 2 diabetes mellitus and its association with glycemic control and its complications. Int J Non Commun Dis. 2021;6:34–7.
Barbagallo M, Dominguez LJ. Magnesium and type 2 diabetes. World J Diabetes. 2015;6(10):1152–7.
Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003;26(4):1147–52.
Sushma S, Devi MSK, Naveen S. The study of relationship between serum magnesium and glycated hemoglobin in clinically uncomplicated type 2 diabetes mellitus patients. J Health Sci Res. 2015;6(1):14.
Nayyar SB, Brar HS, Kukreja S, Kaur K. Study of serum magnesium level in type 2 diabetes mellitus with nephropathy. Int J Adv Med. 2019;6:1145–50.
Rajpoot LS, Dharwadkar KR, Chandrakar S, Jain A, Sharma A. Level with retinopathy in type 2 diabetes mellitus. PJSR. 2021;14(1):18–23.
Rao PP. Estimation of serum magnesium levels and its correlation among patients with diabetic retinopathy. Int J Pharm Pharmaceutical Sci. 2022;14(10):43–45.
Ma J, Folsom AR, Melnick SL. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin and carotid arterial wall thickness: the ARIC study. J Clin Epidemiol. 1995;48(7):927–40.
Mukker P, Narayanan KSK. Case control study evaluating the association of serum magnesium with diabetes mellitus, its microvascular complications and serum lipid profile. J Evid Based Med Healthc. 2019;6(15):1177–83.
de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95(1):1–46.
Downloads
Published
How to Cite
Issue
Section
